Clinical Trials Tracker

Select Clinical Trials Currently Enrolling Patients with Melanoma

June 2017, Vol 7, No 6 - Clinical Trials Tracker

The following clinical trials represent a selection of key studies that are currently recruiting patients with melanoma for inclusion in investigations of new therapies or new regimens of existing treatments for patients with melanoma. Each description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to an appropriate clinical trial. [ Read More ]

Select Clinical Trials Currently Enrolling Patients with Brain Cancer

May 2017, Vol 7, No 5 - Clinical Trials Tracker

The following clinical trials represent a selection of key studies that are currently recruiting patients with brain cancer for inclusion in investigations of new therapies or new regimens of existing treatments for patients with brain cancer. Each description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to an appropriate clinical trial. [ Read More ]

Select Clinical Trials Currently Enrolling Patients with Multiple Myeloma

March 2017, Vol 7, No 3 - Clinical Trials Tracker

The following clinical trials represent a selection of key studies that are currently recruiting patients with multiple myeloma for inclusion in investigations of new therapies or new regimens of existing treatments for patients with multiple myeloma. Each description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to an appropriate clinical trial. [ Read More ]

Select Ongoing Trials Currently Enrolling Patients with Renal-Cell Carcinoma

February 2017, Vol 7, No 2 - Clinical Trials Tracker

The following studies represent a selection of key clinical trials that are currently recruiting patients with renal-cell carcinoma (RCC) for inclusion in investigations of new therapies or new combinations of available therĀ­apies for patients with kidney cancer. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials. [ Read More ]